Search Results 441-450 of 57269 for Compliance

1. SUPRAME-ACTengine® IMA203 Vs. Investigator's Choice Of Treatment In Previously Treated, Unresectable Or Metastatic Cutaneous Melanoma - Mayo Clinic

   ... compliance with clinical trial procedures (e.g., psychiatric disorders or substance dependence, neurological impairment) * Patient has received systemic ...

2. Androgen Deprivation To Enrich PSMA Expression And Improve Sensitivity Of Staging PSMA PET/C - Mayo Clinic

   or psychiatric illness/social situations that would limit compliance with study requirements. Receiving any other investigational agent which would be ...

3. A Study to Determine if a Mask-fitting App Using Facial Recognition Improvea Clinical Care for Patients Using Positive Airway Ppressure Devices?

   Patient interface preference is a key factor in positive airway pressure compliance. Local side effects are common. Proper mask fitting and patient ...

4. Radiation Therapy with or without Temozolomide in Treating Patients with Anaplastic Glioma - Mayo Clinic

   No psychological, familial, sociological, or geographical condition that would potentially hamper compliance with the study protocol and follow-up schedule.

5. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

   ... compliance with study requirements. No current pneumonitis or history of (non-infectious) pneumonitis that required steroids. Human immunodeficiency virus ...

6. SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... compliance with an antihypertensive regimen). Currently receiving treatment with agents that are metabolized solely through cytochrome P450, family 3 ...

7. Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy - Mayo Clinic

   ... compliance with study requirements; Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm; History of ...

8. Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019) - Mayo Clinic

   ... compliance of the administration of the trial medication; Agree to inform their general practitioner of their participation in this study. Inclusion Criteria ...

9. Effects of NNC0194-0499, Cagrilintide, And Semaglutide Alone Or Combined With Semaglutide On Liver Damage And Alcohol Use In Alcohol-Related Liver Disease - Mayo Clinic

   ... compliance with the protocol. A history of a suicidal attempt within 5 years before screeninge. Suicidal ideation corresponding to type 4 or 5 on the ...

10. A Study to Evaluate the Effectiveness, Safety, and Tolerability of NLY01 in Early-stage Parkinson's Disease - Mayo Clinic

    ... compliance or assessment of safety or efficacy. Subject has an ECG or clinical evidence of potentially unstable heart disease, including the following: QTcF ...